本季度信息
华润医药于2026年4月24日发布截至2026年3月31日止三个月的财务业绩。报告期内，营收为28.07亿元（2025年同期为30.79亿元），同比略有下降。净利润为5.01亿元（2025年同期为5.23亿元），同比出现小幅回落。
本季度现金及现金等价物净增加额达到6.58亿元（2025年同期为2.72亿元），期末现金及现金等价物余额为25.66亿元（2025年同期为31.10亿元）。截至2026年3月31日，公司总资产约180.07亿元，总负债约50.05亿元，所有者权益约130.02亿元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.